JMJD1C Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

JMJD1C Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 20 amino acids near the amino terminus of human JMJD1C.

  Source: Synthetic

  (Accession #: NP_116165)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: JMJD1C
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-77072. For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for JMJD1C Antibody Blocking Peptide

• DKFZp761F0118
• EC 1.14.11
• EC 1.14.11.-
• FLJ14374
• JHDM2C
• jumonji domain containing 1C
• Jumonji domain-containing protein 1C
• KIAA1380TR-interacting protein 8
• probable JmjC domain-containing histone demethylation protein 2C
• RP11-10C13.2
• thyroid hormone receptor interactor 8
• thyroid receptor interacting protein 8
• Thyroid receptor-interacting protein 8
• TRIP8
• TRIP-8

Background

JMJD1C is a member of the jumonji (jmj) domain containing gene family of histone demethylases that plays a role in chromatin regulation and influences transcriptional activation and suppression. Some recently characterized members of the jmj family include JARID1A/RBP2, JARID1C, JMJD1A, JMJD1B, JMJD1C, JMJD2A, JMJD2C and JMJD2D. JMJD1C has been identified as a nuclear-receptor coactivator and is a candidate gene for autism.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: JMJD1C